Why Bristol Myers (BMY) is Poised to Beat Earnings Estimates Again

Core Viewpoint - Bristol Myers Squibb (BMY) is positioned well to potentially beat earnings estimates in its upcoming quarterly report, supported by a strong history of exceeding expectations [1]. Group 1: Earnings Performance - The company has a solid track record of surpassing earnings estimates, with an average surprise of 23.29% over the last two quarters [2]. - In the last reported quarter, Bristol Myers achieved earnings of $1.63 per share, exceeding the Zacks Consensus Estimate of $1.48 per share by 10.14% [3]. - For the previous quarter, the company reported earnings of $1.46 per share against an expectation of $1.07 per share, resulting in a surprise of 36.45% [3]. Group 2: Earnings Estimates and Predictions - Recent favorable changes in earnings estimates for Bristol Myers indicate a positive Earnings ESP (Expected Surprise Prediction), suggesting a strong likelihood of an earnings beat [6]. - The current Earnings ESP for Bristol Myers is +5.44%, reflecting increased analyst optimism regarding its near-term earnings potential [9]. - Stocks with a positive Earnings ESP and a Zacks Rank of 3 (Hold) or better have historically produced positive surprises nearly 70% of the time [7].